8-K: Conduit Pharmaceuticals Inc. Announces Change in Independent Registered Public Accounting Firm

Conduit Pharmaceuticals Inc. reports the resignation of Marcum LLP as their independent auditor and the engagement of CBIZ CPAs, effective April 25, 2025.

Summary

• Conduit Pharmaceuticals Inc. announced that Marcum LLP resigned as their independent registered public accounting firm on April 24, 2025.
• The Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm on April 25, 2025.
• Marcum's audit reports for the years ended December 31, 2024 and 2023 contained an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
• There were no disagreements between the Company and Marcum on accounting principles or practices, financial statement disclosure, or auditing scope or procedure.
• Material weaknesses in the Company's internal control over financial reporting were identified during the audits for the fiscal years ended December 31, 2024 and 2023.
• These weaknesses included limited segregation of duties, lack of a formal review process for significant transactions, inadequate internal controls, and inconsistent review of related party transactions.
• The Company provided Marcum with a copy of the Form 8-K and received a letter from Marcum agreeing with the statements made about their firm in the report.

Sentiment

Score: 3

Explanation: The announcement of a change in auditors, coupled with the disclosure of material weaknesses in internal control and a 'going concern' qualification, suggests a negative outlook.

Negatives

• Marcum's audit reports for 2024 and 2023 included an explanatory paragraph regarding the Company's ability to continue as a going concern.
• Material weaknesses were identified in the Company's internal control over financial reporting for the fiscal years ended December 31, 2024 and 2023.
• The Company restated previous periods due to not appropriately reviewing and evaluating the accounting implications of all material transactions that occurred in the audit period.

Risks

• The material weaknesses in internal control over financial reporting could lead to further financial statement errors or irregularities.
• The 'going concern' qualification in the audit reports may make it more difficult for the Company to raise capital.

Industry Context

Changes in auditors are not uncommon, but the circumstances surrounding the change, including the 'going concern' qualification and material weaknesses in internal control, are noteworthy and could raise concerns among investors.

Stakeholder Impact

• Shareholders may be concerned about the material weaknesses in internal control and the 'going concern' qualification.
• Creditors may be less willing to extend credit to the Company due to the 'going concern' qualification.

Key Dates

Keywords

accounting firm, CBIZ CPAs, Marcum LLP, independent auditor, internal control, resignation, engagement, going concern, audit, financial reporting